Primary Graft Failure after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies

Primary Graft Failure after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies

Clinical outcomes after primary graft failure (PGF) remain poor. Here we present a large retrospective analysis (n=23,272) which investigates means to prevent PGF and early detection of patients at high risk. In patients with hematologic malignancies, who underwent their first myeloablative allogene...

Full description

Bibliographic Details
Main Authors: Olsson, Richard F., Logan, Brent R., Chaudhury, Sonali, Zhu, Xiaochun, Akpek, Görgün, Bolwell, Brian J., Bredeson, Christopher N., Dvorak, Christopher C., Gupta, Vikas, Ho, Vincent T., Lazarus, Hillard M., Marks, David I., Ringdén, Olle T.H., Pasquini, Marcelo C., Schriber, Jeffrey R., Cooke, Kenneth R.
Format: Online
Language:English
Published: 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527886/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527886/

Similar Items